Evolus, Inc. (EOLS)Healthcare | Drug Manufacturers - Specialty & Generic | Newport Beach, United States | NasdaqGM
7.10 USD
-0.47
(-6.209%) ⇩
(Oct. 16, 2026, 4 p.m.
EDT)
After hours: 7.10 |
Hot Take ↕ | Oct. 10, 2026, 5:06 a.m. EDT
The investment case here is fundamentally broken. The company is burning cash with negative operating margins and free cash flow, while the balance sheet shows negative book value and debt exceeding cash reserves. Although revenue is growing at 21%, the market has correctly priced this as a value trap; the stock trades at a negative price-to-book ratio, indicating the market believes the assets are worth less than nothing. The recent capital raise and hiring incentives are likely attempts to extend a failing business rather than signs of a turnaround. Short-term, there is a speculative bid. Options data reveals a massive imbalance in call buying, particularly at the $10 and $12.50 strikes, suggesting traders are hoping for a catalyst to spark a rally. However, this is a high-risk gamble against a deteriorating business. The statistical forecast model offers no help, showing a neutral prediction with low confidence, which aligns with the chaotic nature of a distressed stock. Without a clear path to profitability or a massive de-leveraging event, the long-term outlook remains bleak. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.046497 |
| AutoARIMA | 0.055054 |
| AutoETS | 0.055055 |
| MSTL | 0.059736 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 41% |
| H-stat | 0.17 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.357 |
| Excess Kurtosis | -0.57 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 4.855 |
| Market Cap | 468,958,112 |
| Forward P/E | 24.27 |
| Beta | 1.34 |
| Profit Margins | -10.85% |
| Website | https://www.evolus.com |
As of Oct. 10, 2026, 5:06 a.m. EDT: Speculators are positioning for a significant upside move, evidenced by heavy out-of-the-money call open interest at the $10 and $12.50 strikes compared to negligible put volume. This bullish skew suggests bets on a recovery or catalyst-driven rally, despite the underlying stock trading near its 52-week low.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.061285496 |
| Address1 | 520 Newport Center Drive |
| Address2 | Suite 1200 |
| All Time High | 39.5 |
| All Time Low | 2.85 |
| Ask | 7.82 |
| Ask Size | 2 |
| Audit Risk | 7 |
| Average Analyst Rating | 1.5 - Strong Buy |
| Average Daily Volume10 Day | 788,090 |
| Average Daily Volume3 Month | 892,418 |
| Average Volume | 892,418 |
| Average Volume10Days | 788,090 |
| Beta | 1.34 |
| Bid | 4.47 |
| Bid Size | 2 |
| Board Risk | 6 |
| Book Value | -0.468 |
| City | Newport Beach |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 7 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 7.1 |
| Current Ratio | 1.697 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 7.61 |
| Day Low | 7.02 |
| Display Name | Evolus |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,785,961,800 |
| Earnings Call Timestamp Start | 1,785,961,800 |
| Earnings Timestamp | 1,785,960,000 |
| Earnings Timestamp End | 1,793,822,400 |
| Earnings Timestamp Start | 1,793,822,400 |
| Ebitda | -12,774,000 |
| Ebitda Margins | -0.040359996 |
| Enterprise To Ebitda | -46.077 |
| Enterprise To Revenue | 1.86 |
| Enterprise Value | 588,592,128 |
| Eps Current Year | -0.0475 |
| Eps Forward | 0.2925 |
| Eps Trailing Twelve Months | -0.53 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 8.1196 |
| Fifty Day Average Change | -1.0196004 |
| Fifty Day Average Change Percent | -0.12557273 |
| Fifty Two Week Change Percent | 6.1285496 |
| Fifty Two Week High | 9.31 |
| Fifty Two Week High Change | -2.2100005 |
| Fifty Two Week High Change Percent | -0.23737921 |
| Fifty Two Week Low | 3.86 |
| Fifty Two Week Low Change | 3.24 |
| Fifty Two Week Low Change Percent | 0.83937824 |
| Fifty Two Week Range | 3.86 - 9.31 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,518,100,200,000 |
| Float Shares | 49,774,291 |
| Forward Eps | 0.2925 |
| Forward P E | 24.273504 |
| Free Cashflow | -1,819,000 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 353 |
| Fullday Change | -0.47000027 |
| Fullday Change Percent | -6.208722 |
| Fullday Price | 7.1 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.66403 |
| Gross Profits | 210,158,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.11246 |
| Held Percent Institutions | 0.77421 |
| Implied Shares Outstanding | 66,050,440 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California. |
| Long Name | Evolus, Inc. |
| Market | us_market |
| Market Cap | 468,958,112 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_229087176 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -34,333,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 528,403,520 |
| Number Of Analyst Opinions | 5 |
| Open | 7.61 |
| Operating Cashflow | -15,381,000 |
| Operating Margins | -0.051659998 |
| Overall Risk | 7 |
| Phone | 949 284 4555 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 7.1 |
| Post Market Time | 1,792,180,935 |
| Previous Close | 7.57 |
| Price Eps Current Year | -149.47368 |
| Price Hint | 2 |
| Price To Book | -15.17094 |
| Price To Sales Trailing12 Months | 1.4817563 |
| Profit Margins | -0.10848 |
| Quick Ratio | 1.089 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.5 |
| Region | US |
| Regular Market Change | -0.47 |
| Regular Market Change Percent | -6.20872 |
| Regular Market Day High | 7.61 |
| Regular Market Day Low | 7.02 |
| Regular Market Day Range | 7.02 - 7.61 |
| Regular Market Open | 7.61 |
| Regular Market Previous Close | 7.57 |
| Regular Market Price | 7.1 |
| Regular Market Time | 1,792,180,801 |
| Regular Market Volume | 761,676 |
| Return On Assets | -0.05678 |
| Revenue Growth | 0.212 |
| Revenue Per Share | 4.855 |
| Sand P52 Week Change | 0.13723719 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 66,050,440 |
| Shares Percent Shares Out | 0.085200004 |
| Shares Short | 5,628,168 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 5,368,957 |
| Short Name | Evolus, Inc. Common Stock |
| Short Percent Of Float | 0.0863 |
| Short Ratio | 7.64 |
| Source Interval | 15 |
| State | CA |
| Symbol | EOLS |
| Target High Price | 20.0 |
| Target Low Price | 12.0 |
| Target Mean Price | 15.0 |
| Target Median Price | 13.0 |
| Total Cash | 45,170,000 |
| Total Cash Per Share | 0.684 |
| Total Debt | 164,804,000 |
| Total Revenue | 316,488,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.53 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 6.1872 |
| Two Hundred Day Average Change | 0.91279984 |
| Two Hundred Day Average Change Percent | 0.14753036 |
| Type Disp | Equity |
| Volume | 761,676 |
| Website | https://www.evolus.com |
| Zip | 92,660 |